论文部分内容阅读
目的探讨特布他林联合布地奈德雾化吸入治疗支气管哮喘的疗效。方法将82例支气管哮喘患者随机分为治疗组和对照组,每组41例,对照组采用常规药物治疗,治疗组在常规药物治疗基础上应用特布他林联合布地奈德雾化吸入。比较两组患者治疗前后症状、体征消失时间及肺功能改善情况,并比较两组患者临床疗效。结果治疗后治疗组总有效率优于对照组(χ2=4.2486,P<0.05);治疗组主要症状和体征消失时间均明显少于对照组(P<0.05);治疗后两组患者肺功能指标均显著改善,治疗组改善情况优于对照组(P<0.05)。结论布地奈德联合特布他林雾化吸入能够快速缓解支气管哮喘患者症状和体征,改善肺功能,提高临床疗效,可在临床推广应用。
Objective To investigate the therapeutic effect of terbutaline combined with budesonide inhalation on bronchial asthma. Methods Eighty-two patients with bronchial asthma were randomly divided into treatment group and control group, 41 cases in each group. The control group was treated with conventional drugs. The treatment group received inhalation of terbutaline combined with budesonide on the basis of conventional drug therapy. The symptoms, the disappearance of signs and the improvement of pulmonary function were compared between the two groups before and after treatment, and the clinical efficacy was compared between the two groups. Results After treatment, the total effective rate of the treatment group was better than that of the control group (χ2 = 4.2486, P <0.05). The main symptoms and signs disappeared in the treatment group were significantly less than those in the control group (P <0.05) Were significantly improved, the treatment group improved better than the control group (P <0.05). Conclusion Budesonide combined with terbutaline inhalation can quickly relieve the symptoms and signs of patients with bronchial asthma, improve lung function and improve clinical efficacy, which can be popularized and applied clinically.